Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Funding for this research was provided by:
This work was supported by Hailanshen Biomedical Technology Ltd, Shenzhen, China.